Related Experiment Video
Updated: Apr 15, 2026
Probe-based Real-time PCR Approaches for Quantitative Measurement of microRNAs
Published on: April 14, 2015
Comprehensive Analysis of Serum microRNAs in Autoimmune Pancreatitis
Shin Hamada1, Atsushi Masamune, Atsushi Kanno
1Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Background/Aims:
Autoimmune pancreatitis (AIP) is a rare disease that has recently emerged as a unique type of pancreatitis with a presumed autoimmune etiology. MicroRNA (miRNA) is a small non-coding RNA that targets multiple mRNAs. miRNAs might exist in serum in a stabilized form, suggesting its potential application as a biomarker. We here examined the miRNA expression profile in the serum of patients with AIP.
Methods:
miRNAs were prepared from serum samples of patients with various pancreatic diseases (AIP (n = 3, each before and after the steroid therapy), chronic pancreatitis (n = 5), pancreatic cancer (n = 5)) or healthy controls (n = 5). A human miRNA Oligo chip containing approximately 2,000 miRNAs was used to identify differentially expressed miRNAs. Ingenuity Pathway Analysis (IPA) was used for the integrated analysis of altered miRNAs.
Results:
Microarray analysis identified miRNAs highly expressed in the serum of patients with AIP: 13 miRNAs vs. CP, 204 miRNAs vs. pancreatic cancer, and 19 miRNAs vs. healthy controls. miR-150-5p was commonly upregulated in AIP compared to the other samples. IPA revealed the most biological processes affected by the steroid therapy including cellular development, cellular growth, and cell movement.
Conclusion:
Our results identified that miRNAs were differentially expressed in the serum of AIP patients.
Insights
Serum microRNA (miRNA) profiles differ in autoimmune pancreatitis (AIP). This study identified specific differentially expressed miRNAs in AIP patients, suggesting their potential as diagnostic biomarkers for this rare autoimmune disease.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Autoimmune pancreatitis (AIP) is a rare autoimmune disease affecting the pancreas.
- MicroRNAs (miRNAs) are small non-coding RNAs with potential as stable serum biomarkers.
- Understanding miRNA expression in AIP is crucial for diagnosis and management.
Purpose of the Study:
- To investigate the serum miRNA expression profile in patients with autoimmune pancreatitis (AIP).
- To identify specific miRNAs that are differentially expressed in AIP compared to other pancreatic diseases and healthy controls.
- To explore the potential of serum miRNAs as biomarkers for AIP.
Main Methods:
- Serum samples were collected from patients with AIP (before and after steroid therapy), chronic pancreatitis, pancreatic cancer, and healthy controls.
- A human miRNA Oligo chip (~2,000 miRNAs) was employed for differential miRNA expression analysis.
- Ingenuity Pathway Analysis (IPA) was utilized for integrated analysis of altered miRNAs.
Main Results:
- Microarray analysis revealed significant differences in serum miRNA expression in AIP patients compared to controls and other pancreatic diseases.
- Specific miRNAs were found to be highly expressed in AIP: 13 vs. chronic pancreatitis, 204 vs. pancreatic cancer, and 19 vs. healthy controls.
- miR-150-5p was consistently upregulated in AIP patients. IPA indicated that steroid therapy impacts cellular development, growth, and movement.
Conclusions:
- Serum miRNA expression profiles are significantly altered in patients with autoimmune pancreatitis (AIP).
- These findings highlight the potential of specific miRNAs, such as miR-150-5p, as diagnostic biomarkers for AIP.
- Further research can validate these miRNA biomarkers for clinical application in AIP diagnosis and monitoring.
More Related Videos
Related Concept Videos
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment: